Askari F - Search Results

1

Treatment of Wilson disease with ammonium tetrathiomolybdate: III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy.

Brewer GJ, Hedera P, Kluin KJ, Carlson M, Askari F, Dick RB, Sitterly J, Fink JK. Brewer GJ, et al. Among authors: askari f. Arch Neurol. 2003 Mar;60(3):379-85. doi: 10.1001/archneur.60.3.379. Arch Neurol. 2003. PMID: 12633149 Clinical Trial.

2

Treatment of Wilson's disease with zinc. XVIII. Initial treatment of the hepatic decompensation presentation with trientine and zinc.

Askari FK, Greenson J, Dick RD, Johnson VD, Brewer GJ. Askari FK, et al. J Lab Clin Med. 2003 Dec;142(6):385-90. doi: 10.1016/S0022-2143(03)00157-4. J Lab Clin Med. 2003. PMID: 14713890

3

Wilson's disease: clinical management and therapy.

Brewer GJ, Askari FK. Brewer GJ, et al. J Hepatol. 2005;42 Suppl(1):S13-21. doi: 10.1016/j.jhep.2004.11.013. Epub 2004 Dec 18. J Hepatol. 2005. PMID: 15777568 Review. No abstract available.

4

Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease.

Brewer GJ, Askari F, Lorincz MT, Carlson M, Schilsky M, Kluin KJ, Hedera P, Moretti P, Fink JK, Tankanow R, Dick RB, Sitterly J. Brewer GJ, et al. Among authors: askari f. Arch Neurol. 2006 Apr;63(4):521-7. doi: 10.1001/archneur.63.4.521. Arch Neurol. 2006. PMID: 16606763 Clinical Trial.

5

Treatment of Wilson's disease with tetrathiomolybdate: V. Control of free copper by tetrathiomolybdate and a comparison with trientine.

Brewer GJ, Askari F, Dick RB, Sitterly J, Fink JK, Carlson M, Kluin KJ, Lorincz MT. Brewer GJ, et al. Among authors: askari f. Transl Res. 2009 Aug;154(2):70-7. doi: 10.1016/j.trsl.2009.05.002. Epub 2009 Jun 6. Transl Res. 2009. PMID: 19595438

6

Prognostic significance of neurologic examination findings in Wilson disease.

Burke JF, Dayalu P, Nan B, Askari F, Brewer GJ, Lorincz MT. Burke JF, et al. Among authors: askari f. Parkinsonism Relat Disord. 2011 Aug;17(7):551-6. doi: 10.1016/j.parkreldis.2011.05.002. Parkinsonism Relat Disord. 2011. PMID: 21641265

7

Tetrathiomolybdate therapy protects against concanavalin a and carbon tetrachloride hepatic damage in mice.

Askari FK, Dick R, Mao M, Brewer GJ. Askari FK, et al. Exp Biol Med (Maywood). 2004 Sep;229(8):857-63. doi: 10.1177/153537020422900820. Exp Biol Med (Maywood). 2004. PMID: 15337842

8

Treatment of primary biliary cirrhosis with tetrathiomolybdate: results of a double-blind trial.

Askari F, Innis D, Dick RB, Hou G, Marrero J, Greenson J, Brewer GJ. Askari F, et al. Transl Res. 2010 Mar;155(3):123-30. doi: 10.1016/j.trsl.2009.09.009. Epub 2009 Oct 14. Transl Res. 2010. PMID: 20171597 Clinical Trial.

9

Transplant livers in Wilson's disease for hepatic, not neurologic, indications.

Brewer GJ, Askari F. Brewer GJ, et al. Among authors: askari f. Liver Transpl. 2000 Sep;6(5):662-4. doi: 10.1053/jlts.2000.18138. Liver Transpl. 2000. PMID: 11041671 Free article. No abstract available.

10

Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study.

Weiss KH, Askari FK, Czlonkowska A, Ferenci P, Bronstein JM, Bega D, Ala A, Nicholl D, Flint S, Olsson L, Plitz T, Bjartmar C, Schilsky ML. Weiss KH, et al. Lancet Gastroenterol Hepatol. 2017 Dec;2(12):869-876. doi: 10.1016/S2468-1253(17)30293-5. Epub 2017 Oct 5. Lancet Gastroenterol Hepatol. 2017. PMID: 28988934 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

83 results

Search Page